R espiratory failure is one of the commonest causes of admission to the pediatric intensive care unit (PICU). Invasive mechanical ventilation (IMV) is associated with ventilator-induced lung injury and ventilator-associated pneumonia. A tracheal tube may cause subglottic and tracheal injury and ineffective clearance of secretions. Tracheostomy, which is used in patients requiring prolonged mechanical ventilation, is associated with morbidity and mortality, especially in small children (1) (2) (3) (4) (5) .
Positive-pressure support in respiratory failure is critical in stabilizing the airways and the compliant chest wall of the young child. Alveolar ventilation and oxygenation improve, as the work of breathing is reduced. Noninvasive ventilation (NIV) can, to a certain extent, provide the benefits of positive-pressure ventilation without incurring the risks of IMV.
Randomized clinical trials have demonstrated the benefits of NIV in improving the mortality and morbidity in adults with acute exacerbation of chronic obstructive pulmonary disease through the reduction of complications associated with IMV (6 -9) . NIV has become first-line treatment for this condition (10) and is an alternative to immediate intubation in some acute hypoxemic respiratory disorders (11, 12) .
The role of NIV in pediatric chronic respiratory insufficiency of neuromuscular diseases is well established (13) . In recent years, a great deal of the interest in NIV has shifted to the management of acute respiratory failure (ARF) (14, 15) , a condition represented by a relatively heterogeneous group of patients. It has been shown to be feasible in children with a variety of disorders (16, 17) . However, NIV in critically ill children is not without risks, and with failure rates ranging from 8% (14) to 43% (18) , it is essential to define those patients least likely to respond.
Acute respiratory distress syndrome and a high Pediatric Risk of Mortality (PRISM) score have been recognized as risk factors for failure of NIV in both retrospective (19) and prospective studies (18, 20) . A smaller age and weight were predictive but not independent factors of NIV failure (18, 20) .
Our center is a PICU in a middle income country (21) . Equipment and human resources are limited, and demand for beds is high. Turnover in the PICU is, thus, neces-sarily high, and patients must be transferred to the general wards as quickly as possible to make way for new admissions. Having found NIV useful since its implementation in our PICU in 2002, we conducted a prospective observational study from July 2004 to December 2006 to determine the prognostic factors of NIV failure in critically ill children.
MATERIALS AND METHODS
The study was performed in a ten-bed PICU of a university hospital, which received patients from the newborn period until 16 yrs of age. All disciplines were represented except pediatric cardiac surgery. The Ethics Committee of the hospital approved the study and waived the need for informed consent.
All patients who were referred to the PICU for ventilatory support of ARF and those extubated from IMV were eligible for inclusion in the study. The former group of children was described by the attending physician as likely to require intubation, based on a respiratory rate (RR) of Ͼ2 SD for the child's normal age range, increased work of breathing manifested as moderate-to-severe retractions of the chest wall with diminished auscultatory breath sounds, and an oxygen saturation on pulse oximetry of Յ90% on face mask oxygen flow of Ն10 L/min. In the group that had prior IMV, NIV was used after a failed extubation or to facilitate early extubation from IMV. Patients requiring immediate intubation for impending cardiorespiratory collapse, hypotension, recurrent apnea, and Glasgow Coma Scale score of Ͻ10 were excluded.
Protocol for NIV
A suitable nasal or naso-oral mask that provided an optimal fit to the child's face morphology was selected (Sullivan Infant Bubble Mask, ResMed, Bella Vista NSW, Australia; or Small Child Profile Lite Nasal Gel Mask, Respironics, Murrysville, PA). Colloid dressing (DuoDerm, ConvaTec, Skillman, NJ) was placed on different facial pressure points to prevent facial sores. The hose of the mask was connected to a Mapleson F breathing system with an oxygen source supplying a flow of 10 -15 L/min. The mask, with ventilatory ports occluded with adhesive tapes, was adjusted to obtain a good seal without placing undue pressure on the face. When a good seal was achieved, the breathing system was pressurized to provide positive end-expiratory pressure. If the patient had severe respiratory distress, manual bag-mask ventilation was given to synchronize with the patient's breathing effort. Once comfortable, the Velcro straps were fastened to hold the mask in place. The Mapleson F system was disconnected from the hose, which was then connected immediately to a preset ventilator (BiPAP Vision, Respironics). The ventilatory ports of the mask were opened for ventilation. This maneuver was repeated when the mask was removed for suctioning.
Presetting of the NIV
The mode was spontaneous and timed at a rate appropriate for age and respiratory condition; the maximum respiratory rate was 40 breaths/min. Expiratory positive airway pressure was started at 5-8 cm H 2 O, and the inspiratory positive airway pressure (IPAP) provided a pressure support of 6 -8 cm H 2 O. Inspiratory times of 0.5 sec for neonates and 0.6 -0.7 sec for older children were used. The rise time was 0.5% to 1%. FIO 2 was set at 0.4 -0.6. A heated humidifier (Fisher and Paykel Healthcare, Auckland, New Zealand) was used in all cases.
After connection to the NIV, IPAP was adjusted to optimize chest rise and minimize chest retractions and FIO 2 to obtain oxygen saturation on pulse oximetry of about 95%, except in children with chronic lung disease and cyanotic heart disease.
An orogastric tube was inserted. Intubation Criteria. Worsening of respiratory distress manifested by increases in RR or heart rate (HR), reduced breath sounds, oxygen saturation on pulse oximetry of Ͻ95% despite an FIO 2 of Ͼ0.6 or deteriorating conscious level or hemodynamic status.
Criteria for Facilitated Extubation From IMV: These patients were extubated earlier than usual, when breathing with a ventilatory rate was 50% of the normal RR, positive endexpiratory pressure was Յ8 cm H 2 O, pressure support was Յ8 cm H 2 O, and FIO 2 was Ͻ0.4 if an NIV machine was available. Priority was given to patients with underlying heart and lung diseases to shorten the duration of IMV and reduce ventilator-associated pneumonia.
Intensive education was conducted for pediatric critical care clinicians and nurses as well as those from general pediatric wards, as we envisaged the application of NIV outside of the PICU. The training included imparting knowledge of lung and ventilatory mechanics, as well as practical sessions on transitioning the patient to NIV, clinical monitoring, and trouble shooting. Nurses from general wards were rotated to the PICU to learn the practical issues of NIV. A trained nurse provided continuous education and hands-on clinical teaching in the PICU and general wards.
Monitoring
All patients received continuous monitoring of the electrocardiograph, pulse oximetry, and RR. Intermittent observations of blood pressure, temperature, work of breathing (chest retractions), chest rise, auscultatory breath sounds, awareness, and comfort levels were made. Blood gas analysis was not routinely performed.
Data Collection
The demographics, causes of ARF, the underlying diagnosis, and duration of NIV and PICU stay were collected. The PRISM II score (22) and sepsis at the start of NIV were recorded. Sepsis was defined as systemic inflammatory response syndrome in the presence of, or as a result of, a proven infection (23) .
Outcome measurements: Our primary end point was response to NIV and the need for intubation, and secondary end points were improvement in vital signs and work of breathing, mortality, and the duration of NIV. Patients were considered responders when intubation was avoided totally or for at least 5 days; and they were considered nonresponders when they needed intubation within 4 days of starting NIV. Complications, such as skin erosions, health care-associated pneumonia (24) , and gastric distension, were noted.
Data Analysis
Statistical analyses were performed, using SPSS version 11.5.0 (SPSS, Chicago, IL). The chi-square and Mann-Whitney U tests were used where appropriate. Independent predictive factors of nonresponse to NIV (Table 1) were obtained by calculating the hazard ratios, using multivariate Cox proportional hazards regression model (25, 26) after adjusting for significant and clinically important baseline population characteristics (Table 1 ). In this model, criteria for entry and removal were p Ͻ .05 and p Ͼ .10, respectively. The assumption of proportionality was confirmed by plotting the log-negative-log of the Kaplan-Meier estimates of the survival function vs. the log of time, which resulted in parallel curves. The level of statistical significance for all analyses was set at p Ͻ .05, using two-tailed comparisons. The significance level was not changed when multiple comparisons were performed (27) .
RESULTS

Patients
During the 2 1 ⁄2-yr period, 1102 patients were admitted to the PICU; 585 (53.1%) were infants, and 775 (70.3%) required intubation.
A total of 289 children underwent NIV. Eleven of these patients received palliative care and/or continuous positive airway pressure and were excluded. We analyzed 278 children, who underwent NIV as a strategy of respiratory support. Among these patients, 129 (46.4%) were referrals by physicians for management of ARF, and 149 (53.6%) patients (before IMV) received NIV to facilitate early extubation (n ϭ 98) or failed extubation (n ϭ 48).
The median age of patients was 8.7 months (interquartile range ͓IQR͔, 3.1-33.1 months). Infants represented 157 (56.5%) of the NIV population, those Ͻ4 wks of age, 38 (13.1%) and ex-premature babies, 21 (7.3%). The median weight was 5.5 kg (IQR, 3.3-10.8 kg).
The causes of ARF were pneumonia, congestive heart failure, upper airway obstruction, and splinted diaphragm by tumor or ascites, and frequently a combination of the above conditions (Fig. 1) . Asthma and viral bronchiolitis comprised 10.7% of the NIV population. A chronic coexisting condition existed in 71.2% of our patients. These were underlying surgical conditions (41.4%), and/or congenital heart diseases (31.8%), and/or hemato-oncology diseases (37.9%). Table 2 shows the comparison of patients with ARF who did and did not receive prior IMV. The latter group of Data are presented as number (%) or median (interquartile range).
The p values for NIV responder group vs. NIV nonresponder group.
children was significantly older and heavier than those in the former group. Although the PRISM II score was significantly lower in children of the latter group, at initiation of NIV, they were more likely to be septic and less likely to have a normal HR or RR, all p Ͻ.001. There were however, no differences in the initial NIV settings. Six hours post NIV, these children were less likely to have enteric feeds or normal HR or RR. Their FIO 2 requirement was significantly higher, p ϭ .009.
Outcome of NIV
Of the 278 children treated with NIV, 220 (79.1%) responded (mechanical ventilation avoided for 5 days), and among them, 211 (75.9%) did not require intubation at all. Table 1 shows the clinical characteristics of responders and nonresponders to NIV. No significant differences in demographics, receiving sedation before NIV, NIV within 48 hrs of surgery, or prior IMV were noted. Only the PRISM II score at the time of admission was significantly different between the responders and nonresponders of NIV, p Ͻ .001. Figure 2 shows the progressive decrease of RR, HR, and FIO 2 for both responders and nonresponders during NIV therapy. Both RR and FIO 2 were significantly different between the two groups at start, 6 hrs, and 24 hrs of NIV therapy (all p for RR was Ͻ.001; for FIO 2, the respective p was Ͻ.001, .007, .018). On the other hand, the difference in HR was not significant at start of NIV (p ϭ .154) but became significant at 6 hrs and 24 hrs (p ϭ .001, p ϭ .014, respectively). Sedation was used in 68% of cases, but it did not influence the outcome (p ϭ .161).
NIV Complications
Parents complained that the mask was too big for their child in 39 (14%) cases. Pressure sores were observed in 16 (5.8%). Twenty (7.2%) children, 16 of whom had had prior IMV (p ϭ .026), acquired a health care-associated pneumonia. Data are presented as number (%) or median (interquartile range).
The p values for NIV responder group vs. NIV nonresponder group. NIV success was defined as intubation and mechanical ventilation avoided for Ն5 days.
Length of NIV and PICU Stays
The length of PICU stay was significantly different between responders and nonresponders, 7 days (IQR, 4.0 -17.2 days) and 15 days (IQR, 3.2-40.5 days), respectively, p ϭ .017; and between those with prior IMV and those without, 15 days (IQR, 6.0 -32.0 days) and 4.5 days (IQR, 2.0 -9.0 days), respectively, p Ͻ .001. There was no significant difference in the duration of NIV between patients with and without prior IMV, but a significant difference between responders and nonresponders was observed, 6 days (IQR, 3.0 -11.0 days) and 2 days (IQR, 1.0 -3.0 days), respectively, p Ͻ .001.
Mortality
The overall mortality rate in our series was 9.0%; Ͼ50% of these were patients with oncology diseases. A higher mortality rate was observed in nonresponders to NIV, p Ͻ .001, and in children who received prior NIV, p ϭ .008. None of the deaths was related to the use of NIV; nevertheless, four children who had responded to NIV therapy for Ն5 days died of pulmonary hypertensive crisis, liver necrosis, and relapsed acute lymphoblastic leukemia with septic shock.
Predictive Factors
Nonresponders had a higher PRISM II score and were more likely to have an underlying chronic disease (p ϭ .008) and a hematology-oncology condition (p ϭ .025). Sepsis (p Ͻ .001), an abnormal RR for age (p ϭ .009), a higher IPAP (p ϭ .048), expiratory positive airway pressure (p ϭ .017), and FIO 2 at the start of NIV (p Ͻ .001) were characteristics of nonresponders. The 6-hr post NIV observations were significantly associated with a good response if the patient was comfortable (p ϭ .020), had started enteric feeding (p ϭ .038), had normal HR and RR for age (both p Ͻ .001), lower IPAP (p ϭ .006), expiratory positive airway pressure (p ϭ .003), and FIO 2 (p ϭ .005). The multivariate analysis (Table 3) shows that a higher PRISM II score, sepsis, and a higher FIO 2 required at initiation of NIV were independent predictors of NIV failure. The two main causes of failure of NIV were worsening respiratory failure (66%) and septic shock (50%). Ninety-two (33.1%) patients were discharged to the pediatric wards with respiratory physicians and trained nurses for continuation Figure 2 . Evolution of respiratory rate (A), heart rate (B), and fractional oxygen (C) in patients who improved during noninvasive ventilation (NIV responder group) and patients who deteriorated (NIV non-responder group). of NIV for a median period of 10 days (5.2-25.0).
DISCUSSION
Our study in a single-center tertiary PICU in a medium-income country (21) consisted of two groups of children: one group received NIV during the acute phase of ARF and the other received NIV during the recovery phase. Althugh children in the former group were older and had a lower PRISM II score, at the initiation of NIV, they were more likely to have sepsis and abnormal cardiorespiratory status, underlying their ARF. Despite this, both groups were able to tolerate NIV with improvement in cardiorespiratory status.
The median age of our NIV population reflected the age group of our PICU population. They were younger and smaller compared with patients of previous series of NIV (14, 15, 18 -20) . The median duration of NIV in our patients was higher, possibly due to younger age or unresolved underlying disease predisposing them to chronic respiratory insufficiency. Despite the longer duration of NIV, the median length of PICU stay in responders and nonresponders in our patients were similar to those of other series (20) . This could be explained by our practice of discharging patients to the general wards to continue NIV therapy.
The main objective of our study was to identify predictive factors of NIV failure. Three independent risk factors of NIV failure were a higher PRISM II score at admission, the presence of sepsis, and a higher FIO 2 requirement at the start of NIV. Sepsis at the start of NIV has not been identified as a risk factor in previous studies. However, this was a common finding in our patients. Hence, it was important to monitor these patients for progression to septic shock and evaluate their need for IMV. Our study is in agreement with previous studies (19, 20) that have identified a higher PRISM II score as predictive of NIV failure. Although we did not differentiate our patients into type 1 or type 2 ARF, the requirement for a higher FIO 2 at the start of NIV in the nonresponding group in our patients and others (18) might identify these cases as type 1 ARF. Decreases in RR and HR were observed in all patients on NIV therapy, but a lower decrease in RR was associated with failure of NIV (19, 20) . Age and weight were not factors that predicted a poor response to NIV in our study. Neonates, 84% of whom had prior IMV, had a positive response rate of 78.9%.
To our knowledge, this is the largest series of pediatric patients treated with NIV in a medium-income country. Not only were our patients smaller, but 71.2% of them had underlying chronic diseases and required NIV for a longer duration. We believe that our NIV population was representative of PICU patients in developing countries where specialized services, such as pediatric cardiac surgery for small children, are limited and waiting lists are long. Under these circumstances, NIV may be the only strategy to support the chronic respiratory insufficiency and enables these infants to gain enough body weight for surgical correction. Except for one child with spinal muscular atrophy in whom an absent cough reflex necessitated a tracheostomy, we avoided it in all others who required prolonged respiratory support.
We describe a novel method of transitioning the breathless and agitated child into NIV with a Mapleson F system that was crucial in getting the child's acceptance, by avoiding leak-compensation gushes of gas at the same time apposing a good seal. Synchronized manual positivepressure breaths could achieve sufficient lung recruitment to relieve dyspnea, as would the employment of a higher respiratory support to override the patients' own respiratory effort in the initial stages of NIV. With just a very light fit, silicone or gel mask interfaces provided effective seals. Contrary to the experience of failed NIV in all patients with Trisomy 21 (18), we report a positive response rate of 86.6% in 15 such patients.
In our study, we demonstrated that with prior training, clinicians and nurses outside of the PICU can successfully implement NIV therapy, thus living the concept of "PICU without borders" and relieving the limited number of PICU beds for more critically ill children. It cannot be emphasized enough that an education strategy (28) for nurses and health caregivers in the bedside titration of care is the key factor to the success of the NIV program. Nurses play a crucial role in detecting airway obstruction by masks, relieving areas of pressure sores, positioning the child for postural drainage, removing secretions without stressing the child, and last, but not least, calming an agitated child who is mildly sedated.
Limitations
Our study was not a randomized controlled study. Although we did not have the preintubation variables of those with prior IMV, these patients had higher PRISM scores. Routine blood gas sampling was not mandatory in our patients. Although a higher arterial (19) or venous (20) PO 2 was found to be predictive of failure, Bernet et al (18) did not find improvement in blood gas to predict failure of NIV. In most situations, noninvasive monitoring of vital signs and frequent, at-the-bedside, clinical assessment of the work of breathing, chest rise, and patient-ventilator synchrony in a lightly sedated child provided adequate evaluation of the respiratory status. In our PICU where NIV is a familiar technique, it is possible that NIV could be used earlier in the disease if enough NIV machines were available. However, a shortage of resources because of prolonged NIV in some patients would limit this possibility.
CONCLUSION
In a large pediatric population in a single center, NIV represents a viable strategy that provided effective respiratory support and prevented intubation or shortened the duration of IMV in 75.8% of patients in whom it was applied. It is effective even in young infants. Staff training is important and can be done with minimal disruption. Our study suggests that patients with higher PRISM II score and who were septic and required a higher FIO 2 at the initiation of NIV should be closely monitored to ensure stabilization and no progression to septic shock and deterioration of respiratory status. Even after a positive response of Ն2 days, patients might still deteriorate, thus mandating continual vigilance of patients on NIV.
